Revenue rose 37.27% and net profit nearly doubled year-over-year, driven by market recovery and strong R&D investment. Gross margin improved, and cash flow turned positive, with continued focus on innovation and new product launches amid ongoing industry volatility.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.